Evidence map›Paper›PMID 29263145›Full record

ArticleBioscience reports2018

Evaluation of efficacy and safety of Reteplase and Alteplase in the treatment of hyper-acute cerebral infarction.

Zhi-Jian Lin, Hong-Yan Qiu, Xiao-Xin Tong, Yi Guo, Man-Fu Han, Chun-Shui Yang, Kai-Hua Lin, Jun Wu, Xing Li, Yang Yang

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke.Current treatment options in cardiovascular medicine · 2023
    Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Zhi-Jian LinDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen 518036, P.R. China.
Hong-Yan QiuDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen 518036, P.R. China.
Xiao-Xin TongDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen 518036, P.R. China.
Yi GuoDepartment of Neurology, Shenzhen People's Hospital, Shenzhen 518020, P.R. China.
Man-Fu HanDepartment of Neurology, Shenzhen Second People's Hospital, Shenzhen 518305, P.R. China.
Chun-Shui YangDepartment of Neurology, Shenzhen Sixth People's Hospital, Shenzhen 518052, P.R. China.
Kai-Hua LinDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen 518036, P.R. China.
Jun WuDepartment of Neurology, Peking University Shenzhen Hospital, Shenzhen 518036, P.R. China wujunshenzhen@yeah.net.
Xing LiDepartment of Clinical Medicine, Guangdong Medical University, Zhanjiang 524023, P.R. China.
Yang YangDepartment of Clinical Medicine, Guangdong Medical University, Zhanjiang 524023, P.R. China.
Peking University Shenzhen Hospital · CNGuangdong Medical College · CNShenZhen People’s Hospital · CNShenzhen Second People's Hospital · CNShenzhen Sixth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAspirinCerebral InfarctionCholesterolCholesterol, HDLCholesterol, LDLDrug CombinationsFemaleHumansMaleMiddle AgedRecombinant ProteinsTissue Plasminogen ActivatorTriglyceridesAspirinCholesterolCholesterol, HDLCholesterol, LDLDrug CombinationsRecombinant ProteinsreteplaseTissue Plasminogen ActivatorTriglyceridesAlteplaseEfficacyHyper-acute cerebral infarctionReteplaseSafety

Identifiers

PMID29263145
PMCPMC5770574
OpenAlexW2779943148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.